Open Access

Functional analysis of the mRNA profile of neutrophil gelatinase‑associated lipocalin overexpression in esophageal squamous cell carcinoma using multiple bioinformatic tools

  • Authors:
    • Bing-Li Wu
    • Chun-Quan Li
    • Ze-Peng Du
    • Fei Zhou
    • Jian-Jun Xie
    • Lie‑Wei  Luo
    • Jian-Yi Wu
    • Pi-Xian Zhang
    • Li-Yan Xu
    • En-Min Li
  • View Affiliations

  • Published online on: August 7, 2014     https://doi.org/10.3892/mmr.2014.2465
  • Pages: 1800-1812
  • Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Neutrophil gelatinase-associated lipocalin (NGAL) is a member of the lipocalin superfamily; dysregulated expression of NGAL has been observed in several benign and malignant diseases. In the present study, differentially expressed genes, in comparison with those of control cells, in the mRNA expression profile of EC109 esophageal squamous cell carcinoma (ESCC) cells following NGAL overexpression were analyzed by multiple bioinformatic tools for a comprehensive understanding. A total of 29 gene ontology (GO) terms associated with immune function, chromatin structure and gene transcription were identified among the differentially expressed genes (DEGs) in NGAL overexpressing cells. In addition to the detected GO categories, the results from the functional annotation chart revealed that the differentially expressed genes were also associated with 101 functional annotation category terms. A total of 59 subpathways associated locally with the differentially expressed genes were identified by subpathway analysis, a markedly greater total that detected by traditional pathway enrichment analysis only. Promoter analysis indicated that the potential transcription factors Snail, deltaEF1, Mycn, Arnt, MNB1A, PBF, E74A, Ubx, SPI1 and GATA2 were unique to the downregulated DEG promoters, while bZIP910, ZNF42 and SOX9 were unique for the upregulated DEG promoters. In conclusion, the understanding of the role of NGAL overexpression in ESCC has been improved through the present bioinformatic analysis.

Introduction

Neutrophil gelatinase-associated lipocalin (NGAL), also termed lipocalin2, is a member of the lipocalin superfamily, which includes >20 members (1). NGAL is secreted extracellularly and forms a heterodimer with matrix metalloproteinase-9 (MMP-9) through disulfide bonds protecting against degradation (2). NGAL tightly binds to the bacterial siderophore, possibly serving as a potent bacteriostatic agent by sequestering iron as well as regulating innate immunity and inflammation (3). Overexpression of NGAL has also been observed in various types of human cancer, including breast, colorectal, pancreatic, ovarian, gastric, thyroid, ovarian, bladder and kidney cancer (4). Previous studies have shown that NGAL is upregulated in esophageal squamous cell carcinoma (ESCC) and is an independent prognostic factor; this upregulation was significantly correlated with cell differentiation and tumor invasion (5,6).

However, controversial results have been observed regarding the functional role of NGAL in various types of cancer cell. For example, NGAL was able to facilitate gastrointestinal mucosal regeneration by promoting cell motility and invasion and to reduce E-cadherin mediated cell-cell adhesion in colon cancer (7). NGAL was demonstrated to be highly expressed in human thyroid carcinomas, and NGAL knockdown inhibited cancer cell growth in soft agar and the formation of tumors in nude mice (8). Conversely, in pancreatic cancer cells, NGAL reduced adhesion/invasion partly through suppressing focal adhesion kinase activation and inhibited angiogenesis partly by blocking vascular endothelial growth factor production (9).

In the present study, to examine the biological role of NGAL in ESCC, NGAL was overexpressed in the EC109 ESCC cell line. An mRNA microarray was performed using the Agilent whole genome oligo microarray to identify differentially expressed genes (DEGs) in NGAL overexpressing cells compared with control cells (10). Multiple bioinformatics analyses were performed on these DEGs in order to gain a comprehensive understanding of the role of NGAL overexpression in ESCC.

Materials and methods

Differentially expressed genes

The raw data were analyzed using normalization and log transformation (10). Differentially expressed genes were identified using a two-fold change threshold.

Gene ontology (GO) enrichment and functional annotation

The Database for Annotation, Visualization and Integrated Discovery bioinformatics tool (DAVID; http://david.abcc.ncifcrf.gov/) was applied for GO enrichment, using category classes including Biological process, Cellular component and Molecular function. GO is one of the most useful methods for functional annotation and classification of genes. In addition, DAVID bioinformatics provides a functional annotation chart to identify over-represented biological terms from a particular gene list (11). Thus far, the functional annotation chart provides >40 category enrichments, including GO terms, sequence features, disease associations, protein functional domains, protein-protein interactions, pathways, homology, gene functional summaries and literature. The enriched terms from the functional annotation chart with P<0.05 were visualized by the Enrichment Map plugin for the Cytoscape network visualization software (12).

Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and subpathway analysis

The bioconductor SubpathwayMiner package was applied to the DEG-enriched KEGG pathways identified (12). In addition to traditional entire pathway enrichment, SubpathwayMiner is able to detect subpathways, local regions of entire pathways, which aids in gaining more detailed information regarding the relevant genes in localized areas of a specific pathway (13). SubpathwayMiner extracts multiple subpathways from an entire KEGG pathway by the k-clique method. The distance between any two nodes (a node indicates a gene in the pathway) in a subpathway is not larger than k; k was set as 4 in the present study.

Promoter sequence patterns and potential transcription factor analysis

The 2,000-bp promoter sequences of the 20 genes exhibiting the greatest down- and upregulation, respectively, were retrieved from the UCSC genome database (http://genome.ucsc.edu/). The sequence patterns over-represented or under-represented in these two promoter sequence sets were analyzed by the POCO program (http://ekhidna.biocenter.helsinki.fi/poxo/poco/poco). POCO identifies motifs that are over-represented in one dataset compared with a background set, but under-represented in another dataset compared with the same background set. For the parameters in the present study, the background organism was set as homo_sapiens_clean and the longest pattern length was set as 8. Subsequently, significant sequence patterns were screened in the JASPAR transcription factor database (http://jaspar.binf.ku.dk) to identify recognized transcription factors (similarity index >0.70) (14).

Results

GO enrichment and functional annotation

A total of >200 DEGs in the NGAL overexpressing cells were obtained using a two-fold change as the threshold, including 167 upregulated genes and 96 downregulated genes (Table I). To determine the functional classification of the various gene clusters, GO annotation was conducted using DAVID, which constructs statistically significant functional profiles from a set of genes. A total of 75, 8 and 7 significantly enriched GO terms were identified for these DEGs in the Biological process, Cellular component and Molecular function categories, respectively (P<0.05; Fig. 1). Notably, two predominant Biological process term groups were identified. One group comprised 21 immune-associated terms, including response to stress, defense response and regulation of immune response. The other group consisted of 8 terms regarding chromatin structure and gene transcription, including nucleosome assembly, chromatin assembly and protein-DNA complex assembly. These 8 terms contained the same 17 DEGs: HIST1H2AC, HIST2H2AA3, HIST1H2BB, HIST1H2BC, HIST1H1E, HIST1H2BD, HIST1H1C, HIST1H2BE, HIST1H2AG, HIST1H2BF, HIST1H2BG, HIST1H2AD, HIST1H2BH, HIST1H2BO, HIST1H2BM, H2BFS, HIST1H2BK, HIST1H2BL, HIST1H2BI, HIST2H2AC, HIST1H3D and HIST3H2BB. The most significant function in the Molecular function category was DNA-binding; in addition to 17 histone-associated genes, this contained ZMAT1, IFIH1, LMO2, TFCP2L1, SOX2, TP63, DACH1, FOXN4, TAF11 and OASL. In the Cellular component category, a total of 23 genes associated with the extracellular region were identified: SECTM1, RBP4, A2M, C3, CFB, PLBD1, LGALS8, SPINK5, APOL3, CGREF1, SLC1A3, ISG15, SAA1, SERPINA5, AGT, C1RL, KLK10, IGFL2, AGRN, SEPP1, AREG, CASP1 and DEFB1.

Table I

Differentially expressed genes in neutrophil gelatinase-associated lipocalin overexpressing EC109 esophageal squamous cell carcinoma cells, compared with control cells.

Table I

Differentially expressed genes in neutrophil gelatinase-associated lipocalin overexpressing EC109 esophageal squamous cell carcinoma cells, compared with control cells.

A, Upregulated genes

Gene symbolFold change
LCN275.450
BC03431912.960
CGREF18.069
SLC1A37.525
CLGN5.594
SECTM15.505
POPDC35.469
FNDC65.215
FXYD35.102
KLK104.260
CHST24.142
UBD4.122
LGALS84.084
DEFB13.971
PLEKHA43.910
CSAG13.817
LGALS83.719
SPINK53.665
C1orf383.520
RPSAP103.464
PCDHB53.436
DUSP263.416
DDX583.376
LMO23.368
CFB3.352
FOXN43.336
BTN3A33.279
BF5147993.245
AGRN3.240
KIAA06573.177
GLRX3.074
NAALAD23.067
LOC3897723.046
DACH13.044
TP73L3.026
TCEAL23.016
PADI12.991
DYSF2.987
METTL7A2.977
SERPINA52.956
POF1B2.934
SAMD9L2.913
MGC160752.908
RASGEF1A2.904
RBP42.895
IPO132.894
TTTY222.888
HIST1H1C2.781
C15orf592.777
HERC62.774
PLK22.761
CSAG3A2.752
IFI272.734
DOCK112.729
BLOC1S12.723
SLC22A42.704
IFIH12.696
C32.647
ABCA12.627
OASL2.608
ZMAT12.607
UNC5B2.572
FBP12.560
HIST1H2BK2.560
CAMSAP1L12.559
PFTK12.553
HIST1H1E2.550
IFIT22.544
KYNU2.530
RADIL2.495
KYNU2.492
IFIT12.490
PPAPDC32.484
HIST1H2BC2.480
ABCA12.480
CA82.468
AREG2.467
ADD32.455
AF2646212.451
TDRD92.445
LOC3750102.433
BX1153502.433
GRAMD1C2.430
SEPP12.427
ALPPL22.416
SMIM12.408
LOC3915662.406
SAA12.390
AKR1C32.379
HIST2H2AA2.370
IFI442.366
REEP62.361
PREX12.357
S100A32.355
SOX22.348
C9orf92.341
H2BFS2.340
RIMS42.330
HIST1H2BH2.316
HIST1H2BF2.310
PSMB92.307
LOC3750102.290
HIST1H2BE2.286
FLJ200352.285
CSTA2.283
HIST1H2BB2.281
DIO3OS2.270
HIST1H2BM2.268
NID672.260
FAM31C2.257
HKDC12.253
ZMAT12.246
HIST1H2BL2.237
PLSCR42.233
HIST1H2BD2.223
HIST1H2BI2.217
RAD9B2.215
C9orf92.211
BTN3A12.211
HIST1H3D2.210
HERC52.205
TSGA22.204
BC0216772.204
HIST1H2BG2.203
GPNMB2.200
PLBD12.187
PAG12.177
G1P22.175
TPO2.172
HIST1H2BN2.163
A2M2.161
CACNA1D2.156
AGT2.148
NANOS12.147
SLC5A102.138
CASP12.138
FAM26F2.126
PSD32.116
KARCA12.112
CR5962332.099
HIST1H2BO2.094
PLEKHA42.094
APOL32.084
BC0433572.076
CXorf482.076
HIST2H2AC2.076
AF0749862.074
HIST1H2AD2.074
MGC160752.068
IGFL22.064
C1RL2.060
TAF112.048
PHEX2.048
MGC454742.047
ABCG22.046
ADPRHL12.043
HIST1H2AG2.043
OSTbeta2.042
POPDC22.042
RHBDL42.040
GPR1262.037
TFCP2L12.036
PJA12.035
BBS52.035
HRASLS2.035
C18orf562.028
PLCG22.017
MIB22.014
KRAS2.004

B, Downregulated genes

Gene symbolFold change

CHST60.0931
ZNF5210.110
IFI160.155
IFI160.173
DIAPH20.173
SEMA5A0.204
CENTA20.205
CENTA20.212
CPM0.216
KAL10.228
DCN0.237
CXXC40.250
FOXQ10.252
FOS0.268
COL4A30.287
TMEPAI0.294
GUCY1A20.300
CLU0.312
LEPREL20.316
LYPDC10.323
RASGRP30.323
TMEM460.342
OLFML2A0.344
RGS50.359
PLAT0.360
MASK0.363
TMEPAI0.367
SCARA30.368
DISC10.369
SPFH20.370
FOXP10.370
FOXP10.381
FSTL40.383
NPTX10.383
CDK60.387
FAM211B0.391
GPR560.394
OR51B40.400
SERPINE20.400
ATP9B0.400
FZD100.402
NPTX10.404
CR5972400.410
NFKBIZ0.410
CRLF10.426
GPR560.426
ALPL0.428
SQLE0.429
NALP10.432
TGFBR10.434
MGC42940.434
COL4A40.435
KLK10.435
FAM101B0.437
SLC7A130.439
PGCP0.441
LOC1550600.451
MCTP20.452
SGK0.452
FN10.455
EGR10.455
ANKH0.456
SDC20.457
RDH100.458
XYLT10.458
TGFBI0.458
FRY0.459
BAPX10.460
TGFB10.460
HBG10.462
EDIL30.462
SLC38A50.464
TRPM40.468
PMP220.468
FLJ219860.470
NR4A10.470
CPM0.471
ADAMTS50.475
HBG10.476
XAGE20.478
TSHZ20.479
INSIG10.479
RGS220.484
KCNQ10.485
HMGCS10.490
MYO1A0.490
HMGCS10.490
LOC2845420.494
PTPRB0.496

The DEGs were also clustered using the Functional annotation chart in DAVID and the enrichment was visualized by the Enrichment Map plugin for the Cytoscape software. In Fig. 2, a node signifies one functional category and node size corresponds to the number of enriched genes. The color depth corresponds to the significance (P-value) of the terms. Nodes from the same functional category are presented as the same shape. Edges between nodes were depicted when overlapping genes existed between these two nodes. The widths of the lines indicate the number of overlapping genes between the functional groups, which are bigger and the wider with greater numbers. In the 180 total Functional annotation chart enrichments identified, in addition to 101 terms from the three GO categories, 78 terms from the following annotation categories were included: 14 from INTERPRO, 2 from SMART, 30 from SP_PIR_KEYWORDS, 24 from UP_SEQ_FEATURE, 1 from COG_ONTOLOGY, 2 from PIR_SUPERFAMILY, 1 from OMIM_DISEASE and 4 from KEGG_PATHWAY. These results provided a wider overview of the biological impact of NGAL overexpression in ESCC than traditional GO enrichment. Five DEGs were identified in the Homo sapiens (hsa)04350:TGF-beta signaling pathway term, including SMAD9, ACVRL1, TGFBR1, DCN and TGFB1. The autosomal recessive Alport syndrome is a genetic condition characterized by kidney disease, hearing loss and eye abnormalities. The majority of affected individuals experience progressive loss of kidney function, usually resulting in end-stage kidney disease. This disease was detected in the OMIM_DISEASE category containing two risk genes, COL4A4 and COL4A3 (15). In the SP_PIR_KEYWORDS category, 67 genes were enriched when using the Signal term. In addition, 35 genes were observed to be enriched using the Secreted term in SP_PIR_KEYWORDS. Four genes (C3, SAA1, CFB and FN1) were enriched in the acute phase term in SP_PIR_KEYWORDS. The ubl conjugation term in SP_PIR_KEYWORDS contained 27 genes; in addition to 15 histone-associated genes, this also included another 12 genes: TSHZ2, SOX2, TP63, FOS, H2BFS, INSIG1, COL4A3, SGK1, DDX58, PJA1, MIB2 and ADD3. The only enrichment term in COG_ONTOLOGY was DNA replication, recombination and repair, which contained four genes (DDX58, IFIT1, IFIH1 and DDX60).

Pathway and subpathway enrichment

The DEGs were mapped to KEGG pathways to identify the cell signaling pathways influenced by the downstream effectors of NGAL. The DEGs were enriched in only four pathways (Table II).

Table II

Enriched Kyoto Encyclopedia of Genes and Genomes DEG pathways.

Table II

Enriched Kyoto Encyclopedia of Genes and Genomes DEG pathways.

Pathway IDPathwayannMolecule RatioaP-value
05322Systemic lupus erythematosus20/2680.0000
04610Complement and coagulation cascades5/2680.0016
05210Colorectal cancer4/2680.0075
00790Folate biosynthesis2/2680.0077

a annMolecule ratio is how many genes are enriched in a pathway. The first number indicates the number of annotated DEGs in the pathway. The second number signifies the total number of molecules in the pathway.

{ label (or @symbol) needed for fn[@id='tfn2-mmr-10-04-1800'] } DEG, differentially expressed gene.

The local area of an entire pathway was able to be defined by multiple subpathways using the node distance k, which aids in understanding how the indicated genes affect the pathway locally. The DEGs were found to be significantly enriched in 60 subpathways corresponding to 27 entire pathways using the SubpathwayMiner package (Table III). Of note, the mitogen-activated protein kinase (MAPK) signaling pathway (has: 04010) was not detected by the entire pathway enrichment, but was found to be significant in the subpathway analysis, with three subpathways derived from three local areas of this signaling pathway (Fig. 3). The subpathway path:04010_2 contained three DEGs: RASGRP3, KRAS and CACNA1D; path:04010_5 contained TGFB1 and TGFBR1, while path:04010_8 only contained NR4A1. Another pathway detected using this analysis was the TGF-beta signaling pathway (has:04350), which was not identified by entire KEGG pathway enrichment, but four subpathways were detected. Path:04350_6 contained DCN, TGFB1 and TGFBR1. Path:04350_4 and path:04350_7 contained DCN and TGFB1, while path:04350_1 and path:04350_8 contained SMAD9 and TGFBR1.

Table III

Enriched Kyoto Encyclopedia of Genes and Genomes subpathways of differentially expressed genes in neutrophil gelatinase-associated lipocalin overexpressing EC109 esophageal squamous cell carcinoma cells.

Table III

Enriched Kyoto Encyclopedia of Genes and Genomes subpathways of differentially expressed genes in neutrophil gelatinase-associated lipocalin overexpressing EC109 esophageal squamous cell carcinoma cells.

Entire pathway IDEntire pathwaySubpathway IDP-value
Path:04960 Aldosterone-regulated sodium reabsorptionpath:04960_30.0161
path:04960_20.0462
Path:05146Amoebiasispath:05146_80.0124
Path:04662B cell receptor signaling pathwaypath:04662_90.0002
path:04662_40.0005
Path:05142Chagas diseasepath:05142_70.0483
Path:05220Chronic myeloid leukemiapath:05220_50.0015
Path:05210Colorectal cancerpath:05210_70.0077
Path:04610Complement and coagulation cascadespath:04610_70.0008
path:04610_10.0043
path:04610_60.0043
path:04610_40.0375
path:04610_20.0403
path:04610_30.0403
path:04610_50.0432
Path:04060Cytokine-cytokine receptor interactionpath:04060_220.0015
path:04060_440.0244
Path:04623Cytosolic DNA-sensing pathwaypath:04623_10.0364
Path:04512ECM-receptor interactionpath:04512_120.0064
path:04512_210.0364
path:04512_230.0364
path:04512_240.0483
Path:04012ErbB signaling pathwaypath:04012_90.0168
Path:00790Folate biosynthesispath:00790_10.0022
path:00790_40.0022
path:00790_50.0030
path:00790_20.0040
Path:05160Hepatitis Cpath:05160_80.0364
Path:04730Long-term depressionpath:04730_50.0271
Path:04010MAPK signaling pathwaypath:04010_50.0161
path:04010_80.0364
path:04010_20.0393
Path:05218Melanomapath:05218_60.0322
path:05218_30.0492
Path:04621NOD-like receptor signaling pathwaypath:04621_40.0009
path:04621_70.0364
path:04621_60.0483
Path:05223Non-small cell lung cancerpath:05223_40.0432
Path:05212Pancreatic cancerpath:05212_90.0040
Path:05200Pathways in cancerpath:05200_250.0040
path:05200_180.0224
path:05200_30.0248
Path:04145Phagosomepath:04145_20.0483
Path:04622RIG-I-like receptor signaling pathwaypath:04622_10.0027
path:04622_70.0202
path:04622_30.0296
Path:05150Staphylococcus aureus infectionpath:05150_10.0224
path:05150_20.0224
path:05150_70.0348
path:05150_40.0483
Path:00140Steroid hormone biosynthesispath:00140_140.0483
Path:04660T cell receptor signaling pathwaypath:04660_60.0064
path:04660_70.0107
Path:04350TGF-beta signaling pathwaypath:04350_60.0035
path:04350_40.0142
path:04350_70.0296
path:04350_10.0403
path:04350_80.0462
Path:04270Vascular smooth muscle contractionpath:04270_130.0483

[i] ECM, extracellular matrix; MAPK, mitogen-activated protein kinase; NOD, nucleotide-binding oligomerization domain; RIG, retinoic acid-inducible gene; TGF, transforming growth factor.

Promoter sequence patterns and potential transcription factors in upregulated and downregulated genes

The spatial distribution and abundance of promoter cis-elements affects gene expression. The co-expression of upregulated and downregulated genes in NGAL overpressing ECO109 cells was considered to be regulated by specific transcription factors at the transcriptional level. POCO is a software program that is able to identify over-represented and under-represented regulatory patterns among promoter sequence sets of upregulated and downregulated genes. In the present study, a total of 52 significant sequence patterns were identified to be over-represented in the downregulated genes but comparatively under-represented in the upregulated genes, of which the top 20 patterns are presented in Table IV. Conversely, 75 patterns were observed to be over-represented in the upregulated genes and simultaneously under-represented in the downregulated genes; the top 20 patterns are shown in Table V. The identified patterns were 5–8 bp long, containing the four known nucleotides, A, C, G and T, while the rest of the places in a pattern, marked as N, may be any of these (which are variable). Subsequently, all significant patterns were screened with the JASPAR transcription factor database to identify potential transcription factors. A total of 11 patterns corresponding to 14 unique transcription factors were detected (Fig. 4). Of these potential transcription factors, Snail, deltaEF1, Mycn, Arnt, MNB1A, PBF, E74A, Ubx, SPI1 and GATA2 were unique for the downregulated DEG promoters, while bZIP910, ZNF42 and SOX9 were unique for the upregulated DEG promoters. These results indicated that these transcription factors may be associated with specific transcriptional regulation in the downregulated and upregulated DEGs. Although a number of sequence patterns did not correspond to known transcription factors, the possibility and importance in the regulation of DEGs subsequent to NGAL overexpression was not discounted.

Table IV

Sequence patterns over-represented in the downregulated genes, but under-represented in the upregulated genes.

Table IV

Sequence patterns over-represented in the downregulated genes, but under-represented in the upregulated genes.

PatternOCC1 (#PRO/#TOT)OCC2 (#PRO/#TOT)F-scoreP-value
TGNGGNAA42 (19/20)14 (11/18)3803.533.33E-04
CTNNGCTT36 (19/20)12 (10/18)3370.779.24E-04
CACNNNTT116 (20/20)58 (18/18)3160.891.52E-03
TTAANG107 (20/20)42 (13/18)3118.931.67E-03
CTTCNCNC43 (19/20)13 (9/18)3107.021.72E-03
AAGGNG140 (20/20)65 (18/18)3000.422.21E-03
CCNCCTT54 (20/20)19 (10/18)2823.353.36E-03
TTAANGNA48 (19/20)14 (9/18)2771.023.80E-03
CTNNCNTA71 (20/20)35 (15/18)2702.614.47E-03
AANGNGNG106 (20/20)54 (17/18)2665.294.88E-03
GACANNT84 (20/20)40 (15/18)2637.855.21E-03
AANNNGNG372 (20/20)265 (18/18)2629.265.32E-03
GNNAAGA146 (20/20)84 (17/18)2585.595.90E-03
CANNCNTT104 (20/20)50 (16/18)2579.945.97E-03
TNTCCNC149 (20/20)86 (18/18)2575.136.04E-03
GTGGNNAG43 (19/20)15 (10/18)2562.636.22E-03
GAAAGNC35 (18/20)13 (10/18)2530.946.71E-03
CACNCNTT31 (19/20)10 (8/18)2452.328.08E-03
ACANNTNC108 (20/20)56 (15/18)2447.078.18E-03
GNANNANG402 (20/20)277 (18/18)2380.879.57E-03

[i] OCC, total number of patterns within the corresponding cluster sequences; OCC1, downregulated DEG promoter sequence set; OCC2, upregulated DEG promoter sequence set; PRO, total number of sequences with the pattern in the corresponding cluster; TOT, total number of sequences in the corresponding cluster; F-score, analysis of variance between the two input clusters and the background sequence set. DEG, differentially expressed gene.

Table V

Sequence patterns over-represented in the upregulated genes, but under-represented in the downregulated genes.

Table V

Sequence patterns over-represented in the upregulated genes, but under-represented in the downregulated genes.

PatternOCC1 (#PRO/#TOT)OCC2 (#PRO/#TOT)F-ScoreP-value
CTCNA276 (20/20)355 (18/18)5070.509.19E-04
ACNNCANT55 (19/20)97 (18/18)4985.611.05E-03
CTCA331 (20/20)476 (18/18)4740.311.54E-03
TNNAGTCC10 (10/20)31 (18/18)4712.781.61E-03
CAANCT56 (19/20)109 (18/18)4363.702.77E-03
TNCTNAC60 (19/20)103 (18/18)4182.293.68E-03
TCTCA80 (20/20)124 (18/18)4112.354.10E-03
TNNTNGAG66 (20/20)111 (18/18)4083.414.29E-03
GGNNTCAA15 (12/20)42 (18/18)3998.494.90E-03
CTCANT79 (19/20)130 (18/18)3985.145.01E-03
TGAGNNA103 (20/20)158 (18/18)3861.856.07E-03
CTCAA66 (20/20)115 (18/18)3716.147.63E-03
ANNGGNGT55 (19/20)99 (18/18)3684.448.02E-03
TTNGAG78 (20/20)116 (18/18)3519.731.04E-02
TGTNANC64 (18/20)122 (18/18)3507.741.06E-02
ANACC213 (20/20)278 (18/18)3458.471.14E-02
TGGNNTC77 (19/20)128 (18/18)3384.731.28E-02
CCAANCT11 (8/20)33 (18/18)3379.391.29E-02
TTGANNC53 (19/20)93 (18/18)3372.461.31E-02
CCNANNNT285 (20/20)337 (18/18)3362.131.33E-02

[i] OCC, total number of patterns within the sequences of the corresponding cluster; OCC1, downregulated DEG promoter sequence set; OCC2, upregulated DEG promoter sequence set; PRO, total number of sequences with the pattern in the corresponding cluster; TOT, total number of sequences in the corresponding cluster; F-score, result of the analysis of variance between the two input clusters and the background sequence set. DEG, differentially expressed gene.

Discussion

ESCC has one of the highest mortality rates of malignant tumors worldwide, particularly in Asia, with an overall five-year survival rate <20% (16). NGAL has been shown to be an important mediator of invasion and metastasis in ESCC (5,6,10). However, for a improved understanding of the role of NGAL in ESCC, a comprehensive analysis of the mRNA profile of NGAL overexpression ESCC cells was conducted in the present study, using multiple bioinformatic analyses. A total of 267 DEGs were observed in the NGAL overexpressing cells compared with control cells, using a two-fold change as the threshold. To understand the function of these DEGs, the DEGs were analyzed by GO enrichment using DAVID bioinformatics. Several GO terms associated with known NGAL functions were detected. For example, 21 immune-associated terms were identified, including response to stress, defense response and regulation of immune response. In the response to stimulus (GO:0050896) term, >43 genes were enriched. For example, one of the enriched genes, RAD9, protects against genomic instability by activating DNA damage checkpoint and DNA damage repair pathways (17). Another enriched gene, DEFB1, is constitutively expressed in epithelial tissues, but may be upregulated upon receiving inflammatory or microbial stimuli (18).

Recent studies have observed that NGAL is involved in the antibacterial iron-depletion strategy of the innate immune system. NGAL binds catecholate-type siderophores, such as enterobactin synthesized by E. coli, to arrest E. coli growth through inhibiting the iron-uptake ability (19). Several studies found NGAL to be critical in the antimicrobial molecular response in infections, including Salmonella (20,21), Chlamydia (22) and Mycobacterium tuberculosis (23). The GO enrichment analysis in the present study suggested that in addition to NGAL itself, NGAL downstream effectors exert a marked impact on cell immune function and in response to other stimuli, including stress and defense responses.

Of note, 17 histone-associated proteins were upregulated in response to NGAL overexpression. The association between NGAL and histone-associated proteins had not been reported previously, to the best of our knowledge. Therefore, investigating how NGAL influences chromatin structure and gene transcription was of interest. The results of the present study provided novel information regarding the role of NGAL in gene transcriptional regulation through chromatin organization and nucleosome assembly.

The functional annotation chart provided a markedly wider overview of the biological impact of NGAL overexpression in ESCC than traditional GO enrichment. The chart reported that five DEGs were found using the hsa04350:TGF-beta signaling pathway term, which were not identified by the KEGG pathway enrichment analysis. Alport syndrome, which contained COL4A4 and COL4A3, was the only enriched term from the OMIM_DISEASE category listed in the chart. Urine and plasma NGAL have been revealed to be novel biomarkers for diagnosis and outcome prediction in renal dysfunction conditions, including acute kidney injury, chronic kidney disease and renal ischemia-reperfusion injury (2426). The correlation between kidney disease and NGAL interaction with downstream effectors was marked. A total of 67 genes were enriched in the SP_PIR_KEYWORDS signal term and 33 of these genes were contained in the Secreted term.

NGAL is a secreted protein, which forms a complex with MMP-9 to prevent its autodegradation, which is critical for extracellular matrix remodeling (2). Extracellular NGAL has been suggested to cause the secretion of other proteins, such as FN1, which regulate the acute inflammatory response, cell-matrix adhesion and the defense response (27). Four genes, C3, SAA1, CFB and FN1, were enriched in the SP_PIR_KEYWORDS acute phase term. Of note, all four genes are defined as positive acute phase proteins, which are considered to exert the following general functions: Opsonization and trapping of microorganisms and associated microbial products; binding cellular remnants, such as nuclear fractions; scavenging free hemoglobin and radicals; and modulating the immune response of the host (28).

Although an entire pathway may not be identified to be statically significant, alterations in local gene expression levels may affect the local pathway significantly, which results in a marked impact on the biological outcome. Subpathway analysis is a powerful method to detect genes in the local area of the KEGG pathway. Li et al (29) constructed a drug-metabolic subpathway network and found the local region of the tyrosine metabolic pathway to be closely associated with the development of lung cancer. A total of 60 subpathways corresponding to 27 entire pathways were found in the present study. Several subpathway-derived entire pathways were identified using this method. For example, the MAPK signaling pathway and the TGF-beta signaling pathway were detected. These results suggested that although certain DEGs did not significantly affect an entire pathway, they did perturb the pathway locally. Other proteins in these pathways were not differentially expressed at the mRNA level, but this may exclude processes such as modification and complex formation, undergone by the DEGs.

DEGs were classified into upregulated and downregulated genes as determined by the respective expression levels. How these two group genes were co-regulated by distinguishing sequence patterns and transcription factors was notable. The POCO software program identifies over- and under-represented regulatory patterns among the promoter sequence sets of upregulated and downregulated genes. Not all DEGs are considered to be modified at the transcriptional level; the DEGS may have been differentially expressed due to differences in mRNA stability. Thus, in the present study, the 20 genes exhibiting the greatest up- or downregulation in NGAL overexpressing ESCC cells were analyzed by POCO. Hundreds of significant sequence patterns and dozens of transcription factors were found to be over- and under-represented in the downregulation gene set and the upregulation gene set, respectively. This suggested that the change in signal transduction following NGAL overexpression resulted in specific transcription factors and/or certain sequence patterns exerting critical regulatory roles, to achieve co-regulation of the significantly down- or upregulated genes at the transcriptional level.

A number of these potential transcription factors have previously been reported to be associated with cancer invasion or metastasis. Snail and ZEB1 (deltaEF1) are predominantly involved in the repression of E-cadherin expression, resulting in epithelial to mesenchymal transition, which has been implicated as the critical event initiating cancer invasion and metastasis (30,31). Overexpression of Snail was shown to correlate positively with lymphovascular invasion and was associated with poorer overall survival in ESCC patients (32). Nuclear expression of ZEB1 was observed in >33% ESCC tumor cells, while ZEB1 was not detected in the normal adult esophageal epithelia (33). PBF was hypothesized to induce the translocation of PTTG to the cell nucleus, where it induces tumorigenesis via a number of different mechanisms (33). PBF is upregulated by estrogen and mediates estrogen-stimulated cell invasion in breast cancer cells (34). SPI1 co-operates with MYC regulating the transcription of microRNA-29b, which is important in the neutrophil differentiation of acute promyelocytic leukaemia cells (35). Notably, NGAL was first identified as a protein stored in specific granules of human neutrophils (36). A potential SPI1 binding site was identified in the promoter region of the NGAL gene by computer analysis (37). These results indicated that SPI1 may be the key molecule in biological functions mediated by NGAL. SOX9, a high-mobility group box transcription factor, is required for development, differentiation and lineage commitment. Cytoplasmic SOX9 may serve as a valuable prognostic marker in invasive ductal carcinoma and metastatic breast cancer. The significant correlation identified between SOX9 and breast tumor cell proliferation implies that SOX9 directly contributes to the poor clinical outcomes associated with invasive breast cancer (38). These results indicated that these transcription factors may be involved in the invasion or metastasis mediated by NGAL. Although numerous sequence patterns were not matched to known transcription factors, the specific base composition suggested that these patterns may be crucial in transcriptional regulation. These results indicated that these sequence patterns and transcription factors may respond to particular transcriptional regulation in downregulated and upregulated DEGs.

In conclusion, in the present study, a comprehensive understanding of the role of NGAL in ESCC following NGAL overexpression was obtained by multiple bioinformatic analyses, particularly through analyzing subpathway and sequence patterns for co-expression, which provided more information than traditional methods. These analytical methods may be used to search for novel functional genes and pathways associated with the relevant genes identified from high-throughput data.

Acknowledgements

This study was supported by grants from the NSFC-Guangdong Joint Fund (grant no. U0932001), the National Basic Research Program (grant no. 2012CB526608), the National High Technology Research and Development Program of China (grant nos. 2012AA02A503 and 2012AA02A209), the National Science Foundation of China (grant no. 30900560), the Foundation for Distinguished Young Talents in Higher Education of Guangdong (grant no. LYM09081) and Shantou University Medical Research Fund.

References

1 

Flower DR: The lipocalin protein family: structure and function. Biochem J. 318:1–14. 1996.

2 

Yan L, Borregaard N, Kjeldsen L and Moses MA: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 276:37258–37265. 2001. View Article : Google Scholar : PubMed/NCBI

3 

Yang J, Goetz D, Li JY, et al: An iron delivery pathway mediated by a lipocalin. Mol Cell. 10:1045–1056. 2002. View Article : Google Scholar : PubMed/NCBI

4 

Chakraborty S, Kaur S, Guha S and Batra SK: The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta. 1826.129–169. 2012.PubMed/NCBI

5 

Zhang H, Xu L, Xiao D, et al: Upregulation of neutrophil gelatinase associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol. 60:555–561. 2007. View Article : Google Scholar

6 

Du ZP, Lv Z, Wu BL, et al: Neutrophil gelatinase-associated lipocalin and its receptor: independent prognostic factors of oesophageal squamous cell carcinoma. J Clin Pathol. 64:69–74. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Hu L, Hittelman W, Lu T, et al: NGAL decreases E-cadherin- mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab Invest. 89:531–548. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Iannetti A, Pacifico F, Acquaviva R, et al: The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci USA. 105:14058–14063. 2008. View Article : Google Scholar

9 

Tong Z, Kunnumakkara AB, Wang H, et al: Neutrophil gelatinase- associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 68:6100–6108. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Wu B, Li C, Du Z, et al: Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma. Sci Rep. 4:54032014.PubMed/NCBI

11 

Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI

12 

Merico D, Isserlin R, Stueker O, Emili A and Bader GD: Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One. 5:e139842010. View Article : Google Scholar : PubMed/NCBI

13 

Li C, Li X, Miao Y, et al: SubpathwayMiner: a software package for flexible identification of pathways. Nucleic Acids Res. 37:e1312009. View Article : Google Scholar : PubMed/NCBI

14 

Kankainen M and Holm L: POCO: discovery of regulatory patterns from promoters of oppositely expressed gene sets. Nucleic Acids Res. 33(Web Server issue): W427–W431. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Jefferson JA, Lemmink HH, Hughes AE, et al: Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant. 12:1595–1599. 1997. View Article : Google Scholar : PubMed/NCBI

16 

He J, Gu D, Wu X, et al: Major causes of death among men and women in China. N Engl J Med. 353:1124–1134. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Pérez-Castro AJ and Freire R: Rad9B responds to nucleolar stress through ATR and JNK signalling, and delays the G1-S transition. J Cell Sci. 125:1152–1164. 2012.PubMed/NCBI

18 

Prado-Montes de Oca E: Human beta-defensin 1: a restless warrior against allergies, infections and cancer. Int J Biochem Cell Biol. 42:800–804. 2010.PubMed/NCBI

19 

Goetz DH, Willie ST, Armen RS, et al: Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry. 39:1935–1941. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Godinez I, Haneda T, Raffatellu M, et al: T cells help to amplify inflammatory responses induced by Salmonella enterica serotype Typhimurium in the intestinal mucosa. Infect Immun. 76:2008–2017. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Nairz M, Fritsche G, Brunner P, et al: Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur J Immunol. 38:1923–1936. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Rodríguez N, Mages J, Dietrich H, et al: MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae. Physiol Genomics. 30:134–145. 2007.PubMed/NCBI

23 

Martineau AR, Newton SM, Wilkinson KA, et al: Neutrophil- mediated innate immune resistance to mycobacteria. J Clin Invest. 117:1988–1994. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Noto A, Cibecchini F, Fanos V and Mussap M: NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury. Biomed Res Int. 2013:6120322013. View Article : Google Scholar : PubMed/NCBI

25 

Alharazy SM, Kong N, Saidin R, et al: Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease. Angiology. 65:436–442. 2014. View Article : Google Scholar

26 

Sohotnik R, Nativ O, Abbasi A, et al: Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol Renal Physiol. 304:F1099–F1104. 2013. View Article : Google Scholar

27 

Soikkeli J, Podlasz P, Yin M, et al: Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth. Am J Pathol. 177:387–403. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Gruys E, Toussaint MJ, Niewold TA and Koopmans SJ: Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B. 6:1045–1056. 2005. View Article : Google Scholar : PubMed/NCBI

29 

Li C, Shang D, Wang Y, et al: Characterizing the network of drugs and their affected metabolic subpathways. PLoS One. 7:e473262012. View Article : Google Scholar : PubMed/NCBI

30 

Wu Y and Zhou BP: Snail: More than EMT. Cell Adh Migr. 4:199–203. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Schmalhofer O, Brabletz S and Brabletz T: E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 28:151–166. 2009. View Article : Google Scholar : PubMed/NCBI

32 

Kuo KT, Chou TY, Hsu HS, Chen WL and Wang LS: Prognostic significance of NBS1 and Snail expression in esophageal squamous cell carcinoma. Ann Surg Oncol. 19 Suppl 3:S549–S557. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Ohashi S, Natsuizaka M, Naganuma S, et al: A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res. 71:6836–6847. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Smith VE, Franklyn JA and McCabe CJ: Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake. J Endocrinol. 210:157–163. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Batliner J, Buehrer E, Federzoni EA, et al: Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells. Br J Haematol. 157:270–274. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Kjeldsen L, Johnsen AH, Sengeløv H and Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 268:10425–10432. 1993.PubMed/NCBI

37 

Cowland JB and Borregaard N: Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics. 45:17–23. 1997. View Article : Google Scholar

38 

Chakravarty G, Moroz K, Makridakis NM, et al: Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. Exp Biol Med (Maywood). 236:145–155. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2014
Volume 10 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu B, Li C, Du Z, Zhou F, Xie J, Luo LW, Wu J, Zhang P, Xu L, Li E, Li E, et al: Functional analysis of the mRNA profile of neutrophil gelatinase‑associated lipocalin overexpression in esophageal squamous cell carcinoma using multiple bioinformatic tools. Mol Med Rep 10: 1800-1812, 2014
APA
Wu, B., Li, C., Du, Z., Zhou, F., Xie, J., Luo, L. ... Li, E. (2014). Functional analysis of the mRNA profile of neutrophil gelatinase‑associated lipocalin overexpression in esophageal squamous cell carcinoma using multiple bioinformatic tools. Molecular Medicine Reports, 10, 1800-1812. https://doi.org/10.3892/mmr.2014.2465
MLA
Wu, B., Li, C., Du, Z., Zhou, F., Xie, J., Luo, L., Wu, J., Zhang, P., Xu, L., Li, E."Functional analysis of the mRNA profile of neutrophil gelatinase‑associated lipocalin overexpression in esophageal squamous cell carcinoma using multiple bioinformatic tools". Molecular Medicine Reports 10.4 (2014): 1800-1812.
Chicago
Wu, B., Li, C., Du, Z., Zhou, F., Xie, J., Luo, L., Wu, J., Zhang, P., Xu, L., Li, E."Functional analysis of the mRNA profile of neutrophil gelatinase‑associated lipocalin overexpression in esophageal squamous cell carcinoma using multiple bioinformatic tools". Molecular Medicine Reports 10, no. 4 (2014): 1800-1812. https://doi.org/10.3892/mmr.2014.2465